Skip to main content
  • Main menu
  • User menu
  • Search
  • English ▼
    • English
    • Afrikaans
    • Albanian
    • Amharic
    • Arabic
    • Armenian
    • Azerbaijani
    • Basque
    • Belarusian
    • Bengali
    • Bosnian
    • Bulgarian
    • Catalan
    • Cebuano
    • Chichewa
    • Chinese (Simplified)
    • Chinese (Traditional)
    • Corsican
    • Croatian
    • Czech
    • Danish
    • Dutch
    • Esperanto
    • Estonian
    • Filipino
    • Finnish
    • French
    • Frisian
    • Galician
    • Georgian
    • German
    • Greek
    • Gujarati
    • Haitian Creole
    • Hausa
    • Hawaiian
    • Hebrew
    • Hindi
    • Hmong
    • Hungarian
    • Icelandic
    • Igbo
    • Indonesian
    • Irish
    • Italian
    • Japanese
    • Javanese
    • Kannada
    • Kazakh
    • Khmer
    • Korean
    • Kurdish (Kurmanji)
    • Kyrgyz
    • Lao
    • Latin
    • Latvian
    • Lithuanian
    • Luxembourgish
    • Macedonian
    • Malagasy
    • Malay
    • Malayalam
    • Maltese
    • Maori
    • Marathi
    • Mongolian
    • Myanmar (Burmese)
    • Nepali
    • Norwegian
    • Pashto
    • Persian
    • Polish
    • Portuguese
    • Punjabi
    • Romanian
    • Russian
    • Samoan
    • Scottish Gaelic
    • Serbian
    • Sesotho
    • Shona
    • Sindhi
    • Sinhala
    • Slovak
    • Slovenian
    • Somali
    • Spanish
    • Sudanese
    • Swahili
    • Swedish
    • Tajik
    • Tamil
    • Telugu
    • Thai
    • Turkish
    • Ukrainian
    • Urdu
    • Uzbek
    • Vietnamese
    • Welsh
    • Xhosa
    • Yiddish
    • Yoruba
    • Zulu

Main menu

  • Home
  • Content
    • Current
      • JNMT Supplement
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine Technology
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine Technology

Advanced Search

English ▼
  • English
  • Afrikaans
  • Albanian
  • Amharic
  • Arabic
  • Armenian
  • Azerbaijani
  • Basque
  • Belarusian
  • Bengali
  • Bosnian
  • Bulgarian
  • Catalan
  • Cebuano
  • Chichewa
  • Chinese (Simplified)
  • Chinese (Traditional)
  • Corsican
  • Croatian
  • Czech
  • Danish
  • Dutch
  • Esperanto
  • Estonian
  • Filipino
  • Finnish
  • French
  • Frisian
  • Galician
  • Georgian
  • German
  • Greek
  • Gujarati
  • Haitian Creole
  • Hausa
  • Hawaiian
  • Hebrew
  • Hindi
  • Hmong
  • Hungarian
  • Icelandic
  • Igbo
  • Indonesian
  • Irish
  • Italian
  • Japanese
  • Javanese
  • Kannada
  • Kazakh
  • Khmer
  • Korean
  • Kurdish (Kurmanji)
  • Kyrgyz
  • Lao
  • Latin
  • Latvian
  • Lithuanian
  • Luxembourgish
  • Macedonian
  • Malagasy
  • Malay
  • Malayalam
  • Maltese
  • Maori
  • Marathi
  • Mongolian
  • Myanmar (Burmese)
  • Nepali
  • Norwegian
  • Pashto
  • Persian
  • Polish
  • Portuguese
  • Punjabi
  • Romanian
  • Russian
  • Samoan
  • Scottish Gaelic
  • Serbian
  • Sesotho
  • Shona
  • Sindhi
  • Sinhala
  • Slovak
  • Slovenian
  • Somali
  • Spanish
  • Sudanese
  • Swahili
  • Swedish
  • Tajik
  • Tamil
  • Telugu
  • Thai
  • Turkish
  • Ukrainian
  • Urdu
  • Uzbek
  • Vietnamese
  • Welsh
  • Xhosa
  • Yiddish
  • Yoruba
  • Zulu
  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Watch or Listen to JNMT Podcast
  • Visit SNMMI on Facebook
  • Join SNMMI on LinkedIn
  • Follow SNMMI on Twitter
  • Subscribe to JNMT RSS feeds
OtherImaging (JNMT)

Immune checkpoint inhibitor related adverse effects and FDG PET/CT findings

Jan-Henning Schierz, Ismet Sarikaya, Uwe Wollina, Leonore Unger and Ali Sarikaya
Journal of Nuclear Medicine Technology July 2021, jnmt.121.262151; DOI: https://doi.org/10.2967/jnmt.121.262151
Jan-Henning Schierz
1 Municipal Hospital Dresden, Department of Radiology, Dresden, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ismet Sarikaya
2 Kuwait University Faculty of Medicine, Department of Nuclear Medicine, Kuwait, Kuwait;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Uwe Wollina
3 Municipal Hospital Dresden, Department of Dermatology, Dresden, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Leonore Unger
4 Municipal Hospital Dresden, Department of Rheumatology, Dresden, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ali Sarikaya
5 Trakya university Faculty of Medicine, Department of Nuclear Medicine, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

jnmt.121.262151
DOI 
https://doi.org/10.2967/jnmt.121.262151
PubMed 
34330805

Published By 
Society of Nuclear Medicine
Print ISSN 
0091-4916
Online ISSN 
1535-5675
History 
  • Published online July 30, 2021.

Article Versions

  • You are currently viewing a previous version of this article (July 30, 2021 - 12:35).
  • View the most recent version of this article
Copyright & Usage 
Copyright © 2021 by the Society of Nuclear Medicine and Molecular Imaging, Inc.

Author Information

  1. Jan-Henning Schierz1,
  2. Ismet Sarikaya2,
  3. Uwe Wollina3,
  4. Leonore Unger4 and
  5. Ali Sarikaya5
  1. 1 Municipal Hospital Dresden, Department of Radiology, Dresden, Germany;
  2. 2 Kuwait University Faculty of Medicine, Department of Nuclear Medicine, Kuwait, Kuwait;
  3. 3 Municipal Hospital Dresden, Department of Dermatology, Dresden, Germany;
  4. 4 Municipal Hospital Dresden, Department of Rheumatology, Dresden, Germany;
  5. 5 Trakya university Faculty of Medicine, Department of Nuclear Medicine, Turkey
  1. For correspondence or reprints contact: Ismet Sarikaya, Kuwait University Faculty of Medicine, Department of Nuclear Medicine, Kuwait, Kuwait 00000, Kuwait. E-mail: isarikaya99@yahoo.com

Statistics from Altmetric.com

Article has an altmetric score of 1

See more details

Posted by 1 X users
14 readers on Mendeley

Cited By...

  • 16 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Quantitative imaging biomarkers of immune-related adverse events in immune-checkpoint blockade-treated metastatic melanoma patients: a pilot study
    Nežka Hribernik, Daniel T Huff, Andrej Studen, Katarina Zevnik, Žan Klaneček, Hamid Emamekhoo, Katja Škalic, Robert Jeraj, Martina Reberšek
    European Journal of Nuclear Medicine and Molecular Imaging 2022 49 6
  • Imaging assessment of toxicity related to immune checkpoint inhibitors
    Antonia M. Berz, Sarah Boughdad, Naïk Vietti-Violi, Antonia Digklia, Clarisse Dromain, Vincent Dunet, Rafael Duran
    Frontiers in Immunology 2023 14
  • Imaging Findings in Patients with Immune Checkpoint Inhibitor-Induced Arthritis
    Andrés Ponce, Beatriz Frade-Sosa, Juan C. Sarmiento-Monroy, Nuria Sapena, Julio Ramírez, Ana Belén Azuaga, Rosa Morlà, Virginia Ruiz-Esquide, Juan D. Cañete, Raimon Sanmartí, José A. Gómez-Puerta
    Diagnostics 2022 12 8
  • Biology of Cancer and PET Imaging: Pictorial Review
    Ismet Sarikaya
    Journal of Nuclear Medicine Technology 2022 50 2
  • Nano-Chemotherapy synergize with immune checkpoint inhibitor- A better option?
    Xinye Qian, Wang Hu, Jun Yan
    Frontiers in Immunology 2022 13
  • Metabolic and molecular imaging in inflammatory arthritis
    Rita Noversa de Sousa, Koray Tascilar, Giulia Corte, Armin Atzinger, Ioanna Minopoulou, Sarah Ohrndorf, Maximilian Waldner, Christian Schmidkonz, Torsten Kuwert, Ferdinand Knieling, Arnd Kleyer, Andreas Ramming, Georg Schett, David Simon, Filippo Fagni
    RMD Open 2024 10 1
  • Is 18F-FDG-PET/CT an Optimal Imaging Modality for Detecting Immune-Related Adverse Events after Immune-Checkpoint Inhibitor Therapy? Pros and Cons
    William Karlsen, Lin Akily, Monika Mierzejewska, Jacek Teodorczyk, Artur Bandura, Renata Zaucha, Wojciech Cytawa
    Cancers 2024 16 11
  • Cancer Immunotherapy and Medical Imaging Research Trends from 2003 to 2023: A Bibliometric Analysis
    Shuli Tang, Tiantian Fan, Xinxin Wang, Can Yu, Chunhui Zhang, Yang Zhou
    Journal of Multidisciplinary Healthcare 2024 Volume 17
  • Imaging in Rheumatic Immune-related Adverse Events
    Jeremy Zhang, Ruoning Ni, Ibiyemi Oke, Cassandra Calabrese, Jennifer Strouse, Sophia Weinmann, Alexandra Ladouceur
    Rheumatic Disease Clinics of North America 2024 50 2
  • Prolonged generalized immune response on 18F-FDG PET/CT following COVID-19 vaccination
    Devendra A. Sawant, Ali Aria Razmaria, Neeta Pandit-Taskar
    Radiology Case Reports 2023 18 8

Article usage

Article usage: July 2021 to April 2025

AbstractFullPdf
AbstractFullPdf
Jul 20213700
Aug 202134908
Sep 202121304
Oct 202121609
Nov 2021219026
Dec 2021476924
Jan 20223801031
Feb 20223271126
Mar 2022214011
Apr 202215522
May 202218495
Jun 202212166
Jul 20227925
Aug 202296115
Sep 2022183212
Oct 2022168215
Nov 202276229
Dec 2022362136
Jan 2023142638
Feb 2023253729
Mar 2023314331
Apr 2023235731
May 2023175975
Jun 2023208339
Jul 2023125557
Aug 2023289841
Sep 20232710548
Oct 2023199846
Nov 20232315752
Dec 20231113240
Jan 20241184182
Feb 2024186524
Mar 2024156869
Apr 2024158451
May 20241313349
Jun 2024179529
Jul 2024118246
Aug 20241484135
Sep 2024128431
Oct 20241310146
Nov 2024177039
Dec 2024127749
Jan 202587328
Feb 20251413932
Mar 20252316848
Apr 20252420471
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine Technology: 53 (1)
Journal of Nuclear Medicine Technology
Vol. 53, Issue 1
March 1, 2025
  • Table of Contents
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Download PDF
Article Alerts
Email Article
Citation Tools
Share
Immune checkpoint inhibitor related adverse effects and FDG PET/CT findings
Jan-Henning Schierz, Ismet Sarikaya, Uwe Wollina, Leonore Unger, Ali Sarikaya
Journal of Nuclear Medicine Technology Jul 2021, jnmt.121.262151; DOI: 10.2967/jnmt.121.262151
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
Bookmark this article

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Metabolic and molecular imaging in inflammatory arthritis
  • Radiation Treatments, Autoimmune Activation, and PET Imaging
  • Biology of Cancer and PET Imaging: Pictorial Review
  • Google Scholar

Similar Articles

  • Radiation Treatments, Autoimmune Activation, and PET Imaging
See more

Keywords

  • Oncology: General
  • PET
  • PET/CT
  • FDG PET/CT
  • immune checkpoint inhibitor
  • adverse effect
  • autoimmune
SNMMI

© 2025 SNMMI

Powered by HighWire
Alerts for this Article
Sign In to Email Alerts with your Email Address
Email this Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Immune checkpoint inhibitor related adverse effects and FDG PET/CT findings
(Your Name) has sent you a message from Journal of Nuclear Medicine Technology
(Your Name) thought you would like to see the Journal of Nuclear Medicine Technology web site.
Citation Tools
Immune checkpoint inhibitor related adverse effects and FDG PET/CT findings
Jan-Henning Schierz, Ismet Sarikaya, Uwe Wollina, Leonore Unger, Ali Sarikaya
Journal of Nuclear Medicine Technology Jul 2021, jnmt.121.262151; DOI: 10.2967/jnmt.121.262151

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

We use cookies on this site to enhance your user experience

By clicking any link on this page you are giving your consent for us to set cookies.